Integra LifeSciences Holdings Corp. (IART)
13.21
-0.32
(-2.37%)
USD |
NASDAQ |
Oct 16, 16:00
13.22
0.00 (0.00%)
After-Hours: 20:00
Integra LifeSciences Holdings Cash from Investing (Quarterly) : -43.28M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.28M |
| March 31, 2026 | -14.85M |
| December 31, 2025 | -34.91M |
| September 30, 2025 | -15.59M |
| June 30, 2025 | -21.65M |
| March 31, 2025 | -35.92M |
| December 31, 2024 | -4.249M |
| September 30, 2024 | -10.40M |
| June 30, 2024 | -322.20M |
| March 31, 2024 | -53.96M |
| December 31, 2023 | -57.23M |
| September 30, 2023 | -7.697M |
| June 30, 2023 | -15.55M |
| March 31, 2023 | -13.70M |
| December 31, 2022 | -54.82M |
| September 30, 2022 | 14.80M |
| June 30, 2022 | -4.498M |
| March 31, 2022 | -14.07M |
| December 31, 2021 | -27.48M |
| September 30, 2021 | -8.475M |
| June 30, 2021 | -7.917M |
| March 31, 2021 | -117.57M |
| December 31, 2020 | -35.92M |
| September 30, 2020 | -6.718M |
| June 30, 2020 | -3.949M |
| Date | Value |
|---|---|
| March 31, 2020 | -21.48M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -108.84M |
| June 30, 2019 | -17.41M |
| March 31, 2019 | -15.81M |
| December 31, 2018 | -25.33M |
| September 30, 2018 | -16.34M |
| June 30, 2018 | 1.266M |
| March 31, 2018 | -9.298M |
| December 31, 2017 | -983.57M |
| September 30, 2017 | -7.107M |
| June 30, 2017 | -37.52M |
| March 31, 2017 | -193.14M |
| December 31, 2016 | -16.98M |
| September 30, 2016 | -6.707M |
| June 30, 2016 | -18.94M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -37.82M |
| September 30, 2015 | -315.45M |
| June 30, 2015 | -13.11M |
| March 31, 2015 | -5.632M |
| December 31, 2014 | -98.85M |
| September 30, 2014 | -8.775M |
| June 30, 2014 | -9.356M |
| March 31, 2014 | -246.34M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Penumbra, Inc. | -91.09M |
| Boston Scientific Corp. | -1.956B |
| Globus Medical, Inc. | -129.05M |
| Sight Sciences, Inc. | -0.019M |
| Abbott Laboratories | -673.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 22.80M |
| Cash from Financing (Quarterly) | -0.818M |
| Free Cash Flow | 11.60M |
| Free Cash Flow Per Share (Quarterly) | 0.1343 |
| Free Cash Flow to Equity (Quarterly) | 1.069M |
| Free Cash Flow to Firm (Quarterly) | 36.32M |
| Free Cash Flow Yield | 1.13% |